Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Etf Ticker Symbol | Market | Type |
|---|---|---|---|
| First Trust Nasdaq Pharmaceuticals | FTXH | NASDAQ | Exchange Traded Fund |
| Price Change | Change Percent | Etf Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 27.17 | 04:00:06 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 27.17 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 23.85 - 28.41 |
| Last Trade Time | Type | Quantity | Etf Price | Currency |
|---|---|---|---|---|
| - | 0 | 27.17 | USD |
First Trust Nasdaq Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 0 | 0.00 | - | 710k | -156k | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News First Trust Nasdaq Pharm...
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
FTXH Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 26.96 | 27.34 | 26.77 | 27.05 | 2,217 | 0.21 | 0.78% |
| 1 Month | 25.75 | 27.34 | 25.73 | 26.49 | 5,525 | 1.42 | 5.51% |
| 3 Months | 28.16 | 28.41 | 25.73 | 27.28 | 5,220 | -0.99 | -3.52% |
| 6 Months | 24.46 | 28.41 | 24.3671 | 26.75 | 6,891 | 2.71 | 11.08% |
| 1 Year | 26.28 | 28.41 | 23.85 | 26.44 | 8,276 | 0.89 | 3.39% |
| 3 Years | 26.11 | 28.59 | 23.67 | 26.41 | 11,324 | 1.06 | 4.06% |
| 5 Years | 20.52 | 28.59 | 16.28 | 25.65 | 9,565 | 6.65 | 32.41% |
| The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq US Smart Pharmaceuticals Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified. |
